Subclavian ansae stimulation
First Claim
Patent Images
1. A method comprising:
- identifying a human patient as having angina; and
delivering stimulation therapy to a subclavian ansae nerve of a human patient with a stimulation electrode to limit sympathetic nervous system signals in response to identifying a human patient as having angina.
1 Assignment
0 Petitions
Accused Products
Abstract
Techniques for improving cardiac performance by applying stimulation to the subclavian ansae nerve of a patient are disclosed. In one example, a method comprises identifying a human patient as having a cardiac condition, and delivering stimulation therapy to a subclavian ansae nerve of a human patient with a stimulation electrode.
-
Citations
34 Claims
-
1. A method comprising:
-
identifying a human patient as having angina; and delivering stimulation therapy to a subclavian ansae nerve of a human patient with a stimulation electrode to limit sympathetic nervous system signals in response to identifying a human patient as having angina. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 15)
-
-
12. A method comprising:
-
determining a human patient is experiencing angina pectoris; and delivering electrical stimuli to a subclavian ansae nerve in the patient in response to the determination. - View Dependent Claims (16, 17, 18, 19, 20)
-
-
21. A medical system comprising:
-
a set of one or more electrodes; a stimulation generator coupled to the electrodes; and a processor configured to determine a presence of angina and the processor further configured to control the stimulation generator to generate a stimulation therapy signal configured to at least partially block neural activity in a subclavian ansae nerve in a patient to treat the angina, and deliver the stimulation therapy signal via the set of electrodes. - View Dependent Claims (22, 23, 24, 25, 26)
-
-
27. A medical device comprising:
-
means for determining a human patient is experiencing angina pectoris; means for generating a stimulation therapy signal configured to at least partially block neural activity in a subclavian ansae nerve in response to determining the human patient is experiencing angina pectoris; and means for delivering the stimulation therapy signal to the subclavian ansae nerve in a patient.
-
-
28. A method comprising:
-
determining that a patient is experiencing angina; positioning a transcutaneous electrode near subclavian ansae nerve tissue; stimulating the subclavian nerve tissue through the transcutaneous electrode; and determining whether the angina subsided.
-
- 29. A method for treating a patient suffering from angina pectoris, the method comprising delivering, transcutaneously, electrical stimulation therapy to a subclavian ansae nerve in the patient, the stimulation therapy suppressing sympathetic nervous system signals by blocking transmission of neurological signals on the subclavian ansae nerve.
-
31. A method comprising:
-
monitoring a first set of one or more physiological parameters of the patient correlating to a sympathetic tone of a sympathetic nervous system of the patient; monitoring a second set of one or more physiological parameters of the patient correlating to a parasympathetic tone of a parasympathetic nervous system of the patient; identifying a human patient as having angina in response to monitoring one of the first and second set of one or more physiological parameters; and delivering the stimulation therapy to the subclavian ansae nerve based on identifying the human patient as having angina. - View Dependent Claims (32, 33)
-
-
34. A method comprising:
-
identifying a human patient as having angina; and delivering stimulation therapy to a sympathetic nerve of a human patient with a stimulation electrode in response to identifying a human patient as having angina.
-
Specification